Thrombolytic therapy of right heart emboli-in-transit.
Currently, no consensus exists for the appropriate treatment of echocardiographically diagnosed mobile right heart masses giving rise to a high suspicion of migrant thromboembolism in patients with pulmonary embolism. This may lead to unnecessary delay in the implementation of the most appropriate treatment for these patients. Several earlier studies have supported the beneficial role of thrombolytic therapy. We report on an additional two patients with mobile right heart thromboemboli, refractory to systemic anticoagulation, who recovered quickly after initiation of thrombolytic therapy.
Jessurun
G A
GA
University Hospital Groningen, Dept of Cardiology, The Netherlands.
Brügemann
J
J
Hamer
J P
JP
Römer
J P
JP
Lie
K I
KI
D000368:Aged; D004452:Echocardiography; D004617:Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006331:Heart Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D011655:Pulmonary Embolism / Q000150:complications; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D013300:Streptokinase